These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7324955)

  • 1. [Studies on drugs for coronary diseases. II. Synthesis of compounds related to changrolin as potential antiarrhythmic drugs (author's transl)].
    Sun CJ; Zhang XY; Yang XZ; Wang PP; Shen J; Shu Y; Ji RY
    Yao Xue Xue Bao; 1981 Aug; 16(8):564-70. PubMed ID: 7324955
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of antiarrhythmic drug changrolin on myocardial contractility in anesthetized dogs (author's transl)].
    Shen YT; Wu PM; Wan FT; Chen WZ; Dong YL
    Zhongguo Yao Li Xue Bao; 1981 Mar; 2(1):23-6. PubMed ID: 6461194
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular effect of a new antiarrhythmic drug--changrolin (author's transl)].
    Chen WZ; Dong YL; Ding GS
    Yao Xue Xue Bao; 1979 Dec; 14(12):710-4. PubMed ID: 554432
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and antiarrhythmic and parasympatholytic properties of substituted phenols. 1. Heteroarylamine derivatives.
    Stout DM; Matier WL; Barcelon-Yang C; Reynolds RD; Brown BS
    J Med Chem; 1983 Jun; 26(6):808-13. PubMed ID: 6854583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of antiarrhythmic effects of intravenous injections of changrolin and BL-4712A(author's transl)].
    Wang CG; Wang ZM; Zhang YF; Ding GS
    Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):29-31. PubMed ID: 6211899
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiarrhythmic effect of 4-(3',5'-bis ((n-pyrrolidinyl) methyl)-4'-hydroxyanilino) quinazoline (changrolin) on aconitine-induced arrhythmia in rats (author's transl)].
    Wang ZM; Zhang YF; Ding GS
    Yao Xue Xue Bao; 1979 Jul; 14(7):408-11. PubMed ID: 532636
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physiological disposition of changrolin (author's transl)].
    Zeng YL; Yi QC; Gu HM; Qu ZX; Xu GY
    Zhongguo Yao Li Xue Bao; 1981 Sep; 2(3):177-81. PubMed ID: 6462008
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic analysis of changrolin in dogs with arrhythmia.
    Liu CX; Gu YB; Feng JL; Wei GL; Xiao SH; Sun JL
    Yao Xue Xue Bao; 1996; 31(9):666-70. PubMed ID: 9863232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of infusion rate of Changrolin on drug concentration in blood and ECG (author's transl)].
    Qu ZX; Cao CY; Zhuang YH
    Yao Xue Xue Bao; 1980 Aug; 15(8):449-55. PubMed ID: 7211388
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and biological studies of novel 2-aminoalkylethers as potential antiarrhythmic agents for the conversion of atrial fibrillation.
    Plouvier B; Beatch GN; Jung GL; Zolotoy A; Sheng T; Clohs L; Barrett TD; Fedida D; Wang WQ; Zhu JJ; Liu Y; Abraham S; Lynn L; Dong Y; Wall RA; Walker MJ
    J Med Chem; 2007 Jun; 50(12):2818-41. PubMed ID: 17506538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on antiarrhythmics. I. Synthesis of 3,4,5,-trimethoxybenzamide derivatives (author's transl)].
    Liu YS; Zhou ZS; Gu KJ; Liang CY
    Yao Xue Xue Bao; 1981 Feb; 16(2):158-60. PubMed ID: 7304186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of anti-arrhythmic drug changrolin on fast and slow response potentials of myocardial cell of rats].
    Li ZY
    Zhongguo Yao Li Xue Bao; 1982 Sep; 3(3):172-5. PubMed ID: 6216725
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on antiarrhythmics--synthesis of 2-[(alkylamino) methyl]-and 2,6-bis-[(alkylamino) methyl]-4-substituted amino phenols (author's transl)].
    Lin ML; Liu YF; Lu YY; Zhang HQ; Zheng WM
    Yao Xue Xue Bao; 1981 Oct; 16(10):757-61. PubMed ID: 7336936
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems in studying mechanisms of action of antiarrhythmic drugs (author's transl)].
    Hashimoto K
    Kokyu To Junkan; 1978 Oct; 26(10):981-8. PubMed ID: 725349
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential antiarrhythmic agents. I. Antiarrhythmic activity of basic N-(alpha, alpha-dimethylbenzyl)acylamines.
    Akerman B; Lindberg UH
    Acta Pharm Suec; 1984; 21(2):103-8. PubMed ID: 6475539
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intracellular distribution of changrolin (author's transl)].
    Tu ZH; Chen EH; Wu WW; Yang HH
    Yao Xue Xue Bao; 1979; 14(10):594-7. PubMed ID: 539425
    [No Abstract]   [Full Text] [Related]  

  • 17. [2-(2'-hydroxy 2'-substituted) ethyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazines--a novel group of substances with anti-arrhythmia activity].
    Filippova OV; Kryzhanovskiĭ SA; Peresada VP; Likhosherstov AM; Vititnova MB; Kaverina NV; Reznikov KM
    Eksp Klin Farmakol; 2003; 66(3):21-5. PubMed ID: 12924227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of intravenous infusion of changrolin on cardiac function of patients with arrhythmia].
    Shen YT; Xu NS; Gu SL; Wu PM
    Zhongguo Yao Li Xue Bao; 1983 Dec; 4(4):251-3. PubMed ID: 6230869
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential antiarrhythmic agents. II. Antiarrhythmic activity of basic N-(substituted phenyl and benzyl)dipeptides.
    Lindberg UH; Akerman B
    Acta Pharm Suec; 1985; 22(6):321-34. PubMed ID: 3832783
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and antiarrhythmic and parasympatholytic properties of substituted phenols. 3. Modifications to the linkage region (region 3).
    Stout DM; Matier WL; Barcelon-Yang C; Reynolds RD; Brown BS
    J Med Chem; 1985 Mar; 28(3):295-8. PubMed ID: 3973901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.